Bozena Cybulska-Stopa

Chief

Wrocław University of Scince and Technology

Poland

Research Interests

Explore related searches

Professors in Poland Professors in Immunology Immunology professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Bozena Cybulska-Stopa is a Chief at Wrocław University of Science and Technology in Poland. Her research primarily focuses on melanoma treatment strategies, including the use of anti-PD1 immune checkpoint inhibitors and targeted therapies for BRAF-mutated melanoma. She has contributed to significant studies examining survival trends, treatment outcomes, and adverse events related to melanoma therapies.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (10)

Paweł Sobczuk

Medical University of Warsaw

POLAND

View details

Paweł Teterycz

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND

View details

Marco Gaetano Tucci

Assistant Professor

University of Bari

ITALY

View details

Rafal Suwinski

Chair/Professor

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND

View details

Kamil Drucis

Medical University of Gdansk

POLAND

View details

Anna Czarnecka

Professor

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND

View details

Wieslaw Bal

Narodowy Instytut Onkologii im Marii Skłodowskiej-Curie Państwowy Instytut Badawczy w Warszawie

POLAND

View details

Barbara Ziółkowska

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND

View details

Magdalena Rosińska

current position: Head of Department

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND

View details

Piotr Rutkowski

Narodowy Instytut Onkologii im Marii Skłodowskiej-Curie Państwowy Instytut Badawczy w Warszawie

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Bozena Cybulska-Stopa

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Modern Approach to Melanoma Adjuvant Treatment with Anti-PD1 Immune Check Point Inhibitors or BRAF/MEK Targeted Therapy: Multicenter Real-World Report

Long-Term Real-World Outcomes and Safety of Vemurafenib and Vemurafenib + Cobimetinib Therapy in Patients with BRAF-Mutated Melanoma.

The Current Treatment Trends and Survival Patterns in Melanoma Patients with Positive Sentinel Lymph Node Biopsy (SLNB): A Multicenter Nationwide Study

Long Term Results and Prognostic Biomarkers for Anti-PD1 Immunotherapy Used after BRAFi/MEKi Combination in Advanced Cutaneous Melanoma Patients

The Analysis of Trends in Survival for Patients with Melanoma Brain Metastases with Introduction of Novel Therapeutic Options before the Era of Combined Immunotherapy—Multicenter Italian–Polish Report

Systemic treatment in patients with malignant pleural mesothelioma - real life experience.

Is the BRAF mutation still an unfavorable risk factor in patients with metastatic melanoma in the era of modern therapies?

Sequential treatment with targeted and immune checkpoint inhibitor therapies in patients with BRAF positive metastatic melanoma: Real-world data.

Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study

Development of immunity-related adverse events correlates with baseline clinical factors, survival and response to anti-PD-1 treatment in patients with inoperable or metastatic melanoma

Collaborators (10)

Paweł Sobczuk

Paweł Teterycz

Marco Gaetano Tucci

Rafal Suwinski

Kamil Drucis

Anna Czarnecka

Wieslaw Bal

Barbara Ziółkowska

Magdalena Rosińska

Piotr Rutkowski

Make your next move.